Colostrum, often called “liquid gold” , has taken over longevity circles, biohacking podcasts, and premium supplement shelves. Marketed for everything from gut health to immune resilience and anti-aging, its popularity has surged faster than human clinical research.

In Episode 81 of the Orange Pill Podcast, we break down a newly published randomized, double-blind, placebo-controlled clinical trial from the Journal of Functional Foods that finally puts colostrum to the test in adults aged 55–70.

This episode explores what the data actually shows:

• Colostrum’s antibodies survive digestion and remain bioactive in the gut
• IGF-1 levels increased while age-related decline continued in the placebo group
• Participants saw reduced leg fat accumulation, suggesting metabolic preservation
• Markers pointed toward immune priming, not just passive immunity
• No short-term changes in bone density or cognition — a reality check on timelines
• A strong safety profile, with mostly mild, short-term digestive effects

Rather than a miracle cure, this study positions colostrum as a biologically active, patience-requiring intervention for immune and metabolic resilience in aging populations.

Tune in to Episode 81 to understand where colostrum’s real potential lies, and where marketing may be running ahead of science.